Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes
- PMID: 22971876
- DOI: 10.1039/c2nr31865b
Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes
Abstract
Magnetic resonance imaging (MRI) yields high spatially resolved contrast with anatomical details for diagnosis, deeper penetration depth and rapid 3D scanning. To improve imaging sensitivity, adding contrast agents accelerates the relaxation rate of water molecules, thereby greatly increasing the contrast between specific issues or organs of interest. Currently, the majority of T(1) contrast agents are paramagnetic molecular complexes, typically Gd(iii) chelates. Various nanoparticulate T(1) and T(1)/T(2) contrast agents have recently been investigated as novel agents possessing the advantages of both the T(1) contrast effect and nanostructural characteristics. In this minireview, we describe the recent progress of these inorganic nanoparticle-based MRI contrast agents. Specifically, we mainly report on Gd and Mn-based inorganic nanoparticles and ultrasmall iron oxide/ferrite nanoparticles.
Similar articles
-
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p. Acc Chem Res. 2009. PMID: 19534516 Review.
-
Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.Nanotechnology. 2011 Jun 17;22(24):245604. doi: 10.1088/0957-4484/22/24/245604. Epub 2011 Apr 21. Nanotechnology. 2011. PMID: 21508500
-
Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.Langmuir. 2010 Apr 20;26(8):5753-62. doi: 10.1021/la903566y. Langmuir. 2010. PMID: 20334417
-
Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.Phys Chem Chem Phys. 2012 Feb 28;14(8):2631-6. doi: 10.1039/c2cp23196d. Epub 2012 Jan 25. Phys Chem Chem Phys. 2012. PMID: 22273844
-
Contrast agents: magnetic resonance.Handb Exp Pharmacol. 2008;(185 Pt 1):135-65. doi: 10.1007/978-3-540-72718-7_7. Handb Exp Pharmacol. 2008. PMID: 18626802 Review.
Cited by
-
Plasmonic gadolinium oxide nanomatryoshkas: bifunctional magnetic resonance imaging enhancers for photothermal cancer therapy.PNAS Nexus. 2022 Jul 29;1(4):pgac140. doi: 10.1093/pnasnexus/pgac140. eCollection 2022 Sep. PNAS Nexus. 2022. PMID: 36714874 Free PMC article.
-
Hybrid nanotrimers for dual T1 and T2-weighted magnetic resonance imaging.ACS Nano. 2014 Oct 28;8(10):9884-96. doi: 10.1021/nn500188y. Epub 2014 Oct 8. ACS Nano. 2014. PMID: 25283972 Free PMC article.
-
Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.Nanotheranostics. 2019 Apr 19;3(2):166-178. doi: 10.7150/ntno.31164. eCollection 2019. Nanotheranostics. 2019. PMID: 31183312 Free PMC article.
-
The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances.Molecules. 2020 Nov 1;25(21):5072. doi: 10.3390/molecules25215072. Molecules. 2020. PMID: 33139643 Free PMC article. Review.
-
Structure-Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging.Adv Mater. 2019 Feb;31(8):e1804567. doi: 10.1002/adma.201804567. Epub 2019 Jan 2. Adv Mater. 2019. PMID: 30600553 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical